GlassScriptPhysician profile
Sandra Golamco
NPI 1427045533
$13,398.76
in general payments reported to CMS, 2019-2025
36 companies · $2,538 in 2025
The $2,538 reported for 2025 was more than what 95% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.43 · 2020: $974 · 2021: $1,373 · 2022: $2,256 · 2023: $2,998 · 2024: $3,194 · 2025: $2,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,990 · Travel and Lodging: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,989.68 |
| Travel and Lodging | $740.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,132.83 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Spr Therapeutics, INC | $1,532.59 | 2022-2025 | Sprint Pns System |
| Abbvie INC. | $1,093.01 | 2021-2025 | |
| Nevro Corp. | $637.06 | 2021-2024 | Senza |
| Nalu Medical, INC. | $537.70 | 2024-2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $519.40 | 2021-2024 | Relistor |
| Stimwave Technologies Incorporated | $418.07 | 2021-2022 | |
| Abbott Laboratories | $380.35 | 2021-2023 | Proclaim |
| Lundbeck LLC | $316.29 | 2023-2025 | Vyepti |
| Grt US Holding, INC. | $233.17 | 2021-2022 | |
| Lilly USA, LLC | $228.43 | 2022-2023 | Reyvow, Emgality |
| Curonix LLC | $222.35 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $201.92 | 2019-2024 | Evenity, Prolia |
| Collegium Pharmaceutical, INC. | $164.84 | 2022-2024 | Belbuca, Xtampza |
| Vertos Medical, INC. | $113.65 | 2024 | Mild Device Kit |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $73.61 | 2022-2024 | Kloxxado |
| Scilex Pharmaceuticals INC. | $57.41 | 2019-2021 | |
| Pfizer INC. | $53.18 | 2023-2024 | |
| Allergan, INC. | $51.53 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $48.03 | 2024-2025 | |
| Spinefrontier, INC. | $42.85 | 2024 | Sijfuse |
| Protega Pharmaceutials INC | $37.62 | 2025 | Roxybond |
| Uswm, LLC | $32.22 | 2021 | |
| Biodelivery Sciences International, INC. | $30.95 | 2021 | |
| Saluda Medical Americas, INC. | $30.58 | 2024-2025 | Evoke |
| Kowa Pharmaceuticals America, INC. | $28.32 | 2022 | |
| Zimmer Biomet Holdings, INC. | $24.95 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Globus Medical, INC. | $24.42 | 2025 | Senza |
| Stryker Corporation | $23.05 | 2025 | Mild Device Kit |
| Averitas Pharma INC. | $21.53 | 2024 | Qutenza |
| Amneal Pharmaceuticals LLC | $19.38 | 2023 | Lyvispah |
| Depuy Synthes Sales INC. | $15.95 | 2025 | Orthovisc, Monovisc |
| Redhill Biopharma INC. | $13.56 | 2022 | |
| Orthogenrx INC. | $13.40 | 2021 | |
| Daiichi Sankyo INC. | $12.62 | 2019 | |
| Siemens Medical Solutions USA, INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Golamco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.